Sign in

    Sarah Morin

    Research Analyst at Piper Sandler Companies

    Sarah Morin is an Analyst at Piper Sandler & Co., specializing in equity research since joining the firm in 2023. She covers targeted sectors as part of Piper Sandler’s research team, leveraging regulatory industry knowledge and analysis—though specific covered companies and detailed performance metrics, such as success rates or returns, are not publicly documented. Prior to joining Piper Sandler, her professional trajectory and previous industry affiliations are not extensively disclosed, but she brings current FINRA registration as evidence of her compliance and qualifications within the financial industry. Sarah is registered as a broker with FINRA, demonstrating her professional credentials and regulatory standing in the securities sector.

    Sarah Morin's questions to PERRIGO Co (PRGO) leadership

    Sarah Morin's questions to PERRIGO Co (PRGO) leadership • Q1 2025

    Question

    Sarah Morin, on behalf of Korinne Wolfmeyer, questioned the timing and scope of planned price increases to offset tariffs and asked for an update on the progress of brand divestitures mentioned at the Investor Day.

    Answer

    CEO Patrick Lockwood-Taylor stated that the company is working with retailers on oral care pricing actions, which will include a mix of in-sourcing and price adjustments expected to occur in the next three months. CFO Eduardo Bezerra added that while work on potential divestitures continues, there has been a slight pause on some U.S. market actions due to the macro environment, with a continued focus on the international portfolio.

    Ask Fintool Equity Research AI